ASTEC — Astec Lifesciences Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹24.36bn
- IN₹28.63bn
- IN₹6.28bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.12 | 3.08 | 3.39 | 5.54 | 4.73 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,512 | 2,022 | 2,177 | 3,147 | 1,952 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,485 | 3,318 | 3,304 | 5,157 | 4,989 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,835 | 2,142 | 3,232 | 3,514 | 4,292 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,611 | 5,717 | 6,776 | 8,968 | 9,794 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,488 | 3,184 | 3,223 | 4,906 | 5,262 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,586 | 3,252 | 3,684 | 5,003 | 5,601 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 2,025 | 2,466 | 3,092 | 3,965 | 4,194 |
Total Liabilities & Shareholders' Equity | 4,611 | 5,717 | 6,776 | 8,968 | 9,794 |
Total Common Shares Outstanding |